ID: ALA2069619

Max Phase: Preclinical

Molecular Formula: C40H42N10O2

Molecular Weight: 694.84

Molecule Type: Small molecule

Representations

Canonical SMILES:  O=C(CCN1CCCC1)Nc1cccc(-n2cc(-c3ccc4ccc(-c5cn(-c6cccc(NC(=O)CCN7CCCC7)c6)nn5)cc4c3)nn2)c1

Standard InChI:  InChI=1S/C40H42N10O2/c51-39(15-21-47-17-1-2-18-47)41-33-7-5-9-35(25-33)49-27-37(43-45-49)30-13-11-29-12-14-31(24-32(29)23-30)38-28-50(46-44-38)36-10-6-8-34(26-36)42-40(52)16-22-48-19-3-4-20-48/h5-14,23-28H,1-4,15-22H2,(H,41,51)(H,42,52)

Standard InChI Key:  LZNHTDOJRPGWFX-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 694.84

Molecular Weight (Monoisotopic): 694.3492

AlogP: 6.18

#Rotatable Bonds: 12

Polar Surface Area: 126.10

Molecular Species: BASE

HBA: 10

HBD: 2

#RO5 Violations: 2

HBA (Lipinski): 12

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 3

CX Acidic pKa: 13.59

CX Basic pKa: 9.74

CX LogP: 5.98

CX LogD: 1.93

Aromatic Rings: 6

Heavy Atoms: 52

QED Weighted: 0.16

Np Likeness Score: -1.12

References

1. Lombardo CM, Welsh SJ, Strauss SJ, Dale AG, Todd AK, Nanjunda R, Wilson WD, Neidle S..  (2012)  A novel series of G-quadruplex ligands with selectivity for HIF-expressing osteosarcoma and renal cancer cell lines.,  22  (18): [PMID:22889802] [10.1016/j.bmcl.2012.07.009]

Source

Source(1):

• Scientific Literature